"Dr. Carolyn Savioz is certified by the American Board of Radiology with a subcertification radiation oncology. She earned her medical degree from Wake Forest University and completed her residency at the University of Pittsburgh Cancer Institute."

During the past decade, Radiation Oncology Practice Corporation Southwest conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 11 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radiation Oncology Practice Corporation Southwest" #1 collaborator was "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator and "Gynecologic Oncology Group" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Radiation Oncology Practice Corporation Southwest" are "Cervical Adenocarcinoma" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials), "Recurrent Uterine Corpus Carcinoma" (2 trials), "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (1 trials) and "Adenocarcinoma of the Colon" (1 trials). Many other conditions were trialed in "Radiation Oncology Practice Corporation Southwest" in a lesser frequency.

Most popular intervention types in "Radiation Oncology Practice Corporation Southwest" are "Drug" (17 trials), "Other" (11 trials), "Biological" (8 trials), "Radiation" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (4 trials), "Bevacizumab" (3 trials), "Cisplatin" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Radiation Oncology Practice Corporation Southwest" are 10 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Radiation Oncology Practice Corporation Southwest". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Radiation Oncology Practice Corporation Southwest, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Radiation Oncology Practice Corporation Southwest, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".